Respiratory syncytial virus Primary Antibodies

Respiratory syncytial virus Novocastra

Human infant lung, post-mortem tissue: immunohistochemical staining for Respiratory syncytial virus (RSV) using NCL-RSV3. Note intense staining of infected luminal bronchial epithelial cells. Paraffin section.
Human infant lung, post-mortem tissue: immunohistochemical staining for Respiratory syncytial virus (RSV) using NCL-RSV3. Note intense staining of infected luminal bronchial epithelial cells. Paraffin section.

Antigen Background

Respiratory syncytial virus (RSV) is the most important respiratory pathogen of childhood and is responsible for approximately 50 percent of all cases of bronchiolitis and 25 percent of all cases of pneumonia during the first few months of life. Approximately one percent of babies who develop an RSV infection between two and six months die, particularly those with congenital heart defects, bronchopulmonary dysplasia, low birth weight or immunodeficiency. The virus is also associated with significant lower respiratory disease in elderly and immunosuppressed individuals in whom mortality rates may be high. Multiple types and subtypes of RSV cocirculate in the population.

Product Specific Information

NCL-RSV3 is a cocktail of four antibodies. NCL-RSV3 does not cross-react with Parainfluenza virus types 1, 2, 3 and 4b, Adenovirus, Mumps virus, Measles virus, Influenza virus types A and B, Poliovirus types 1, 2 and 3, Coxsackie B4 virus, Echovirus 19, Varicella-zoster virus, Cytomegalovirus and Herpes simplex virus types 1 and 2.


loading...

CLONE: 5H5N/2G122/5A6/1C3

Material with code "RSV3" is discontinued , possible alternatives:

製品の注文はこちら

商品番号 商品名 Configuration Use Datasheet MSDS 数量
RSV3 1ml NCL-RSV3 Lyophilised Monoclonals F, I, P(HIER) Info MSDS 1